Highlights in acute lymphoblastic leukemia from ASH 2021 include pediatric regimens for adults, CNS involvement, and a possible transplant-sparing regimen, as reported by Dr Mark Litzow.

Chemotherapy-free regimens in Philadelphia chromosome–positive acute lymphoblastic leukemia and optimization of combination therapies are among advances from ASH 2023 chosen by Dr Hagop Kantarjian.

Acute lymphoblastic leukemia has a good outlook or prognosis in children but a poorer outlook in adults. Infant variety of ALL however has a poor prognosis. Survival rates.

Acute lymphoblastic leukemia (ALL) represents around 70% of pediatric leukemia. In high-income countries, the 5-year survival is above 90%, but survival in low- and middle-income countries is inferior ...

Acute lymphoblastic leukemia most commonly affects children below 15 years of age. It is rare among adults. The symptoms are usually slow in onset but may rapidly get severe as the number of ...

PURPOSEAsparaginase-associated pancreatitis (AAP) is common in patients with acute lymphoblastic leukemia (ALL), but risk differences across age groups both in relation to first-time AAP and after ...

Source Reference: Gupta S, et al "Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children" N Engl J Med 2024; DOI: 10.1056/NEJMoa2411680.

Cycle Pharma enters exclusive US commercialization agreement with Handa for Phyrago to treat two types of leukaemia, Ph+ CML & Ph+ ALL: Cambridge, UK Wednesday, July 23, 2025, 16: ...